These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14723959)

  • 41. Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors.
    Inglis SR; Zervosen A; Woon EC; Gerards T; Teller N; Fischer DS; Luxen A; Schofield CJ
    J Med Chem; 2009 Oct; 52(19):6097-106. PubMed ID: 19731939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.
    Szermerski M; Melesina J; Wichapong K; Löppenberg M; Jose J; Sippl W; Holl R
    Bioorg Med Chem; 2014 Feb; 22(3):1016-28. PubMed ID: 24412340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stereoselective synthesis of polyhydroxylated amines using (S)-pyroglutamic acid derivatives].
    Ikota N
    Yakugaku Zasshi; 2014; 134(1):77-88. PubMed ID: 24389621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Benzyl-3,4-iminobutanoic acid as inhibitor of carboxypeptidase A.
    Park JI; Kim DH
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2967-70. PubMed ID: 11677137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors.
    Grant EB; Guiadeen D; Baum EZ; Foleno BD; Jin H; Montenegro DA; Nelson EA; Bush K; Hlasta DJ
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2179-82. PubMed ID: 11012024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 47. The perfect penicillin? Inhibition of a bacterial DD-peptidase by peptidoglycan-mimetic beta-lactams.
    Josephine HR; Kumar I; Pratt RF
    J Am Chem Soc; 2004 Jul; 126(26):8122-3. PubMed ID: 15225046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of beta-lactamase inhibitors.
    Jackson D
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The enigmatic catalytic mechanism of active-site serine beta-lactamases.
    Galleni M; Lamotte-Brasseur J; Raquet X; Dubus A; Monnaie D; Knox JR; Frère JM
    Biochem Pharmacol; 1995 May; 49(9):1171-8. PubMed ID: 7763298
    [No Abstract]   [Full Text] [Related]  

  • 50. The glucose-specific carrier of the Escherichia coli phosphotransferase system.
    García-Alles LF; Navdaeva V; Haenni S; Erni B
    Eur J Biochem; 2002 Oct; 269(20):4969-80. PubMed ID: 12383255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Competitive inhibition of a glutamate carboxypeptidase by phosphonamidothionate derivatives of glutamic acid.
    Rodriguez CE; Lu H; Dinh TT; Mlodnosky KL; Dastgah A; Lam VQ; Nichols CB; Berkman CE
    Bioorg Med Chem Lett; 1999 May; 9(10):1415-8. PubMed ID: 10360747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?
    Greenwood D
    J Antimicrob Chemother; 1996 Jul; 38(1):17-20. PubMed ID: 8858452
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The absolute configuration of belactin A, a beta-lactone-containing serine carboxypeptidase inhibitor: importance of the beta-lactone structure for serine carboxypeptidase inhibition.
    Murakami S; Takahashi Y; Takeuchi T; Kodama Y; Aoyagi T
    J Enzyme Inhib; 1999; 14(6):437-46. PubMed ID: 10536877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parallel solid-phase synthesis of 3beta-peptido-3alpha-hydroxy-5alpha-androstan-17-one derivatives for inhibition of type 3 17beta-hydroxysteroid dehydrogenase.
    Maltais R; Luu-The V; Poirier D
    Bioorg Med Chem; 2001 Dec; 9(12):3101-11. PubMed ID: 11711285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delta 2- and delta 3-cephalosporins, penicillinate and 6-unsubstituted penems. Intrinsic reactivity and interaction with beta-lactamases and D-alanyl-D-alanine-cleaving serine peptidases.
    Frère JM; Kelly JA; Klein D; Ghuysen JM; Claes P; Vanderhaeghe H
    Biochem J; 1982 Apr; 203(1):223-34. PubMed ID: 6980645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-Benzyl-2-methylsuccinic acid as inhibitor for carboxypeptidase A. synthesis and evaluation.
    Lee M; Jin Y; Kim DH
    Bioorg Med Chem; 1999 Aug; 7(8):1755-60. PubMed ID: 10482467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biosynthesis and molecular genetics of clavulanic acid.
    Jensen SE; Paradkar AS
    Antonie Van Leeuwenhoek; 1999; 75(1-2):125-33. PubMed ID: 10422585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.